, Volume 67, Issue 2, pp 181–188 | Cite as

Modification of different morphine actions by 6-hydroxydopamine and 6-hydroxydopamine plus desmethylimipramine

  • V. Fuchs
  • H. Coper
Original Investigations


After intracisternal 6-hydroxydopamine (6-OHDA) in mice, brain noradrenaline (NA) and dopamine (DA) are diminished, although the reduction of NA is more pronounced. Intracisternal injection of 6-OHDA in desmethylimipramine (DMI)-pretreated animals strengthens the depletion of DA while NA is partly protected. The concentration of 5-hydroxytryptamine (5-HT) is not influenced by 6-OHDA or 6-OHDA +DMI. Chronic morphine treatment to some extent enhances reduced NA and DA levels after 6-OHDA, but the decreased central catecholamine (CA) content after 6-OHDA+DMI is not raised. Morphine analgesia is highly attenuated in 6-OHDA and 6-OHDA +DMI mice. the reduction occurs in nontolerant as well as in tolerant animals. The acute effect of morphine on body temperature is abolished with 6-OHDA, but not with 6-OHDA+DMI, whereas the interaction of central CA in morphine-induced running shows distinctly marked reduction with 6-OHDA +DMI, but not with 6-OHDA. Acute toxicity is enhanced by 6-OHDA+DMI whereas the development of tolerance against the toxicity of morphine is diminished by 6-OHDA. Lack of CA in the brain decreases sensitivity against naloxone withdrawal in acute as well as in chronic experiments.

Key words

Mice 6-OHDA 6-OHDA+DMI Morphine Analgesia Body temperature Motility Lethality Physical dependence 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Atack, C. V., Lindqvist, M.: Conjoint native orthophthaldialdehyde-condensate assays for the fluorometric determination of 5-hydroxyindoles in brain. Naunyn Schmiedeberg's Arch. Pharmacol. 279, 267–284 (1973)Google Scholar
  2. Ayhan, I. H.: Effects of 6-OHDA on morphine analgesia. Psychopharmacologia 25, 183–188 (1972)Google Scholar
  3. Bhargava, H. N., Afifi, A. H., Way, E. L.: Effect of chemical sympathectony on morphine antinociception and tolerance development in the rat. Biochem. Pharmacol. 22, 2769–2772 (1973)Google Scholar
  4. Bläsig, J., Herz, A., Gramsch, C.: Effects of depletion of brain catecholamines during the development of morphine dependence on precipitated withdrawal in rats. Naunyn Schmiedeberg's Arch. Pharmacol. 286, 325–336 (1975)Google Scholar
  5. Bloom, F. E., Algeri, S., Groppetti, A., Revuetta, A., Costa, E.: Lesions of central norepinephrine terminals with 6-OH-dopamine: Biochemistry and fine structure. Science 166, 1284–1286 (1969)Google Scholar
  6. Breese, G. R., Taylor, T. D.: Effects of 6-hydroxydopamine on brain norepinephrine and dopamine. Evidence for selective degeneration of catecholamine neurons. J. Pharmacol. Exp. Ther. 174, 413–420 (1970)Google Scholar
  7. Breese, G. R., Taylor, T. D.: Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine. Br. J. Pharmacol. 42, 88–99 (1971)Google Scholar
  8. Brittain, R. T.: The intracerebral effects of noradrenaline and its modification by drugs in the mouse. J. Pharm. Pharmacol. 18, 621–623 (1966)Google Scholar
  9. Brittain, R. T., Handley, S. L.: Temperature changes produced by the injection of catecholamines and 5-hydroxytryptamine into the cerebral ventricles of the conscious mouse. J. Physiol. (Lond.) 192, 805–814 (1967)Google Scholar
  10. Castellano, C., Llovera, B. E., Oliverio, A.: Morphine-induced running and analgesia in two strains of mice following septal lesions or modification of brain amines. Naunyn Schmiedeberg's Arch. Pharmacol. 288, 355–370 (1975)Google Scholar
  11. Cavalli-Sforza, L.: Biometrie, Grundzüge biologisch-medizinischer Statistik. Stuttgart: Fischer 1969Google Scholar
  12. Eddy, N. B., Leimbach, D.: Synthetic analgesics. Dithenylbutanol and dithenylbutylamines. J. Pharmacol. Exp. Ther. 107, 385–393 (1953)Google Scholar
  13. Elchisak, M. A., Rosencrans, J. A.: Development of morphine tolerance and physical dependence in rats depleted of brain catecholamines by 6-hydroxydopamine. Neuropharmacology 18, 175–182 (1979)Google Scholar
  14. Estler, C. J.: Effects of α- and β-adrenergic blocking agents and parachlorophenylalanine on morphine and caffeine-stimulated locomotor activity in mice. Psychopharmacologia 28, 261–268 (1973)Google Scholar
  15. Feldberg, W., Myers, R. D.: Effects on temperature of amines injected into the cerebral ventricles. A new concept in temperature regulation. J. Physiol. (Lond.) 173, 226–237 (1964)Google Scholar
  16. Feldberg, W., Lotti, V. J.: Temperature changes produced in the unanesthetized rat by monoamines and tranylcypromine injected into the cerebral ventricles. J. Physiol. (Lond.) 191, 35–36 (1967)Google Scholar
  17. Fernandes, M., Kluwe, S., Coper, H.: Quantitative assessment of tolerance to and dependence on morphine in mice. Naunyn Schmiedeberg's Arch. Pharmacol. 297, 53–60 (1977)Google Scholar
  18. Friedler, G., Bhargava, H. N., Quock, R., Way, E. L.: The effect of 6-hydroxydopamine on morphine tolerance and physical dependence. J. Pharmacol. Exp. Ther. 183, 49–55 (1972)Google Scholar
  19. Goldstein, A., Sheehan, P.: Tolerance to opioid narcotics. Tolerance to the “running-fit” caused by levorphanol in the mouse. J. Pharmacol. Exp. Ther. 169, 175–184 (1969)Google Scholar
  20. Hattan, D. G., Wolf, H. H.: Effects of intrahypothalamic 6-hydroxydopamine on central thermoregulatory responses to (+)-and (-)-norepinephrine and dopamine. Neuropharmacology 16, 639–648 (1977)Google Scholar
  21. Hedreen, J. C., Chalmers, J. P.: Neuronal degeneration in rat brain induced by 6-hydroxydopamine. A histological and biochemical study. Brain Res. 47, 1–36 (1972)Google Scholar
  22. Hellon, R. F.: Monoamines, pyrogens and cations: Their actions on central control of body temperature. Pharmacol. Rev. 26, 289–321 (1974)Google Scholar
  23. Hollinger, M.: Effects of reserpine, α-methyl-p-tyrosine, p-chlorophenylalanine, and pargyline on levorphanol-induced running activity in mice. Arch. Int. Pharmacodyn. Ther. 179, 419–424 (1969)Google Scholar
  24. Huidobro, F., Maggiolo, G.: Some features of the abstinence syndrome to morphine in mice. Acta Physiol. Lat. Am. 11, 201–209 (1961)Google Scholar
  25. Kalant, H., LeBlanc, A. E., Gibbins, R. J.: Tolerance to and dependence on some nonopiate psychotropic drugs. Pharmacol. Rev. 23, 135–191 (1971)Google Scholar
  26. Kruk, Z. L.: The effect of drugs acting on dopamine receptors on the body temperature of the rat. Life Sci. 11, 845–850 (1972)Google Scholar
  27. Lagerspetz, K. Y. H., Koprowsky, H., Darnell, M., Tarkkonen, H.: Thermoregulation in group B arbovirus resistant and group B arbovirus susceptible mice. Am. J. Physiol. 225, 532–537 (1973)Google Scholar
  28. Loy, D. L., Taam, D. W., Wurtman, R. J.: Blockade of endotoxininduced hypothermia by pretreatment with intracisternal 6-hydroxydonamine. Life Sci. 13, 485–492 (1973)Google Scholar
  29. Myers, R. D.: Handbook of drug and chemical stimulation of the brain. New York: Van Nostrand Reinhold 1974Google Scholar
  30. Nakamura, K., Kuntzman, R., Maggio, A. C., Agulis, V., Conney, A. H.: Influence of 6-hydroxydopamine on the effect of morphine on the tail-flick-latency. Psychopharmacologia 31, 177–189 (1973)Google Scholar
  31. Oliverio, A., Castellano, C.: Genotype-dependent sensitivity and tolerance to morphine and heroin: Dissociation between opiateinduced running and analgesia in the mouse. Psychopharmacologia 39, 13–22 (1974)Google Scholar
  32. Rethy, C. R., Smith, C. B., Villarreal, J. E.: Effects of narcotic analgesics upon the locomotor activity and brain catecholamine content of the mouse. J. Pharmacol. Exp. Ther. 176, 472–479 (1971)Google Scholar
  33. Samanin, R., Bernascoin, S.: Effects of intraventricularly injected 6-OHDA or midbrain raphe lesion on morphine analgesia in rats. Psychopharmacologia 25, 175–182 (1972)Google Scholar
  34. Shuster, L., Hannam, R. V., Boyle, W. E., Jr.: A simple method for producing tolerance to dihydromorphine in mice. J. Pharmacol. Exp. Ther. 140, 149–154 (1963)Google Scholar
  35. Somerville, A. R., Whittle, B. A.: The interrelation of hypothermia and depletion of noradrenaline, dopamine and 5-hydroxytryptamine from brain by reserpine, p-chlorophenylalanine and α-methyltyrosine. Br. J. Pharmacol. Chemother. 31, 120–130 (1967)Google Scholar
  36. Svensson, T. H., Waldeck, B.: On the significance of central noradrenaline for motor activity. Experiments with a new dopamine-β-hydroxylase inhibitor. Eur. J. Pharmacol. 7, 278–282 (1969)Google Scholar
  37. Uretzky, N. J., Iversen, L. L.: Effects of 6-hydroxydopamine on noradrenaline-containing neurons in the rat brain. Nature 221, 557–559 (1969)Google Scholar
  38. Villarreal, J. E., Guzman, M., Smith, C. B.: A comparison of the effect of d-amphetamine and morphine upon locomotor activity of mice treated with drugs which alter brain catecholamine content. J. Pharmacol. Exp. Ther. 187, 1–7 (1973)Google Scholar
  39. Way, E. L., Loh, H. H., Shen, F. H.: Smultaneous quantitative assessment of morphine tolerance and physical dependence. J. Pharmacol. Exp. Ther. 167, 1–8 (1969)Google Scholar
  40. York, J. L., Maynert, E. W.: Alteration in morphine analgesia produced by chronic deficits of brain catecholamines or serotonin. Role of analgesimetric procedure. Psychopharmacology 56, 119–125 (1978)Google Scholar

Copyright information

© Springer-Verlag 1980

Authors and Affiliations

  • V. Fuchs
    • 1
  • H. Coper
    • 1
  1. 1.Institut für Neuropsychopharmakologie der Freien Universität BerlinBerlin 19

Personalised recommendations